Paper33809702
A Novel Precision Approach to Overcome the "Addiction Pandemic" by Incorporating Genetic Addiction Risk Severity (GARS) and Dopamine Homeostasis Restoration.
Blum K and 13 others. J Pers Med, 2021. Cited by 23 papers, by iCite.
Cite this record
ConductScience Library. A Novel Precision Approach to Overcome the "Addiction Pandemic" by Incorporating Genetic Addiction Risk Severity (GARS) and Dopamine Homeostasis Restoration. Papers, record 33809702. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33809702
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A Novel Precision Approach to Overcome the "Addiction Pandemic" by Incorporating Genetic Addiction Risk Severity (GARS) and Dopamine Homeostasis Restoration.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| I01 CX000479/CX/CSRD VA/United States | VA | United States | I01CX000479 | PubMed | NIH RePORTER |
| R41 MD012318/MD/NIMHD NIH HHS/United States | Health and Health Services Research Fund | R41MD012318 | PubMed | NIH RePORTER |
References110
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21084795 | Acute intravenous synaptamine complex variant KB220™ "normalizes" neurological dysregulation in patients during protracted abstinence from alcohol and opiates as observed using quantitative electroencephalographic and genetic analysis for reward polymorphisms: part 1, pilot study with 2 case reports. | Postgrad Med | 2010 | https://conductscience.org/library/papers/21084795 | PubMed |
| 2 | 8632351 | Differential coupling of rat D2 dopamine receptor isoforms expressed in Spodoptera frugiperda insect cells. | J Pharmacol Exp Ther | 1996 | https://conductscience.org/library/papers/8632351 | PubMed |
| 3 | 28274137 | Post-traumatic stress symptoms in pathological gambling: Potential evidence of anti-reward processes. | J Behav Addict | 2017 | https://conductscience.org/library/papers/28274137 | PubMed |
| 4 | 31820688 | Hypodopaminergia and "Precision Behavioral Management" (PBM): It is a Generational Family Affair. | Curr Pharm Biotechnol | 2020 | https://conductscience.org/library/papers/31820688 | PubMed |
| 5 | 23926462 | Neurogenetics and Nutrigenomics of Neuro-Nutrient Therapy for Reward Deficiency Syndrome (RDS): Clinical Ramifications as a Function of Molecular Neurobiological Mechanisms. | J Addict Res Ther | 2012 | https://conductscience.org/library/papers/23926462 | PubMed |
| 6 | 9160798 | Putative oxidative metabolites of 1-methyl-6-hydroxy-1,2,3,4-tetrahydro-beta-carboline of potential relevance to the addictive and neurodegenerative consequences of ethanol abuse. | Alcohol | 1997 | https://conductscience.org/library/papers/9160798 | PubMed |
| 7 | 3067616 | Mechanism and regulation of ethanol elimination in humans: intermolecular hydrogen transfer and oxidoreduction in vivo. | Alcohol Clin Exp Res | 1988 | https://conductscience.org/library/papers/3067616 | PubMed |
| 8 | 26450814 | Dopamine Depletion Reduces Food-Related Reward Activity Independent of BMI. | Neuropsychopharmacology | 2016 | https://conductscience.org/library/papers/26450814 | PubMed |
| 9 | 28951609 | Rehabilitating the addicted brain with transcranial magnetic stimulation. | Nat Rev Neurosci | 2017 | https://conductscience.org/library/papers/28951609 | PubMed |
| 10 | 31833150 | Cannabis use, depression and self-harm: phenotypic and genetic relationships. | Addiction | 2020 | https://conductscience.org/library/papers/31833150 | PubMed |
| 11 | 30348770 | Cocaine reward is reduced by decreased expression of receptor-type protein tyrosine phosphatase D (PTPRD) and by a novel PTPRD antagonist. | Proc Natl Acad Sci U S A | 2018 | https://conductscience.org/library/papers/30348770 | PubMed |
| 12 | 31093318 | Buprenorphine and Methadone as Opioid Maintenance Treatments for Heroin-Addicted Patients Induce Oxidative Stress in Blood. | Oxid Med Cell Longev | 2019 | https://conductscience.org/library/papers/31093318 | PubMed |
| 13 | 26724386 | Dopaminergic Neurons and Brain Reward Pathways: From Neurogenesis to Circuit Assembly. | Am J Pathol | 2016 | https://conductscience.org/library/papers/26724386 | PubMed |
| 14 | 23827972 | Pain and suicidality: insights from reward and addiction neuroscience. | Prog Neurobiol | 2013 | https://conductscience.org/library/papers/23827972 | PubMed |
| 15 | 32609628 | Co-occurrences of substance use and other potentially addictive behaviors: Epidemiological results from the Psychological and Genetic Factors of the Addictive Behaviors (PGA) Study. | J Behav Addict | 2020 | https://conductscience.org/library/papers/32609628 | PubMed |
| 16 | 29379966 | Conceptualizing Addiction From an Osteopathic Perspective: Dopamine Homeostasis. | J Am Osteopath Assoc | 2018 | https://conductscience.org/library/papers/29379966 | PubMed |
| 17 | 32432229 | Addiction by Any Other Name is Still Addiction: Embracing Molecular Neurogenetic/Epigenetic Basis of Reward Deficiency. | J Addict Sci | 2020 | https://conductscience.org/library/papers/32432229 | PubMed |
| 18 | 30197787 | "Dopamine homeostasis" requires balanced polypharmacy: Issue with destructive, powerful dopamine agents to combat America's drug epidemic. | J Syst Integr Neurosci | 2017 | https://conductscience.org/library/papers/30197787 | PubMed |
| 19 | 29512887 | Opioid and nondopamine reward circuitry and state-dependent mechanisms. | Ann N Y Acad Sci | 2019 | https://conductscience.org/library/papers/29512887 | PubMed |
| 20 | 32934823 | Improving naltrexone compliance and outcomes with putative pro- dopamine regulator KB220, compared to treatment as usual. | J Syst Integr Neurosci | 2020 | https://conductscience.org/library/papers/32934823 | PubMed |
Cited by21
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42072408 | A Personalized Medicine Approach: Psychosocial and Genetic Risk Assessments Predictors of Bariatric Surgery Outcomes After 3 Years. | Biomedicines | 2026 | https://conductscience.org/library/papers/42072408 | PubMed |
| 41249063 | Billions Spent, Few Saved: Rethinking National Institutes of Health HEAL Initiative in Light of Dopaminergic Alternatives to the Opioid Trap. | Int J Spine Surg | 2025 | https://conductscience.org/library/papers/41249063 | PubMed |
| 40933508 | Precision Genomics: A Reality Having Universal Impact in a New Era of Psychiatry - Lessons Learned, Past and Present. | J Addict Psychiatry | 2025 | https://conductscience.org/library/papers/40933508 | PubMed |
| 40742457 | A GWAS Meta-meta-analysis and In-depth Silico Pharmacogenomic Investigations in Identification of APOE and Other Genes Associated with Pain, Anti-inflammatory, and Immunomodulating Agents in Opioid Use Disorder (OUD) Derived from 14.91 M Subjects. | Cell Mol Neurobiol | 2025 | https://conductscience.org/library/papers/40742457 | PubMed |
| 40247807 | A Comprehensive 4-layered In Silico Pharmacogenomics Analysis of the Genetic Addiction Risk Severity (GARS) Test: Strong Genetic Evidence Supporting GARS as a Novel Personalized Pre-addiction Assessment Tool in the Opioid Crisis Era. | Curr Pharm Biotechnol | 2025 | https://conductscience.org/library/papers/40247807 | PubMed |
| 39507617 | The First Pilot Epigenetic Type Improvement of Neuropsychiatric Symptoms in a Polymorphic Dopamine D2 (-DRD2/ANKK (Taq1A)), OPRM1 (A/G), DRD3 (C/T), and MAOA (4R) Compromised Preadolescence Male with Putative PANDAS/CANS: Positive Clinical Outcome with Precision-Guided DNA Testing and Pro-Dopamine Regulation (KB220) and Antibacterial Therapies. | Open J Immunol | 2024 | https://conductscience.org/library/papers/39507617 | PubMed |
| 39411118 | A Complex Relationship Among the Circadian Rhythm, Reward Circuit and Substance Use Disorder (SUD). | Psychol Res Behav Manag | 2024 | https://conductscience.org/library/papers/39411118 | PubMed |
| 38765881 | Summary Document Research on RDS Anti-addiction Modeling: Annotated Bibliography. | J Addict Psychiatry | 2024 | https://conductscience.org/library/papers/38765881 | PubMed |
| 38561465 | Differential DNA methylation in iPSC-derived dopaminergic neurons: a step forward on the role of SNORD116 microdeletion in the pathophysiology of addictive behavior in Prader-Willi syndrome. | Mol Psychiatry | 2024 | https://conductscience.org/library/papers/38561465 | PubMed |
| 37885438 | Invited Expert Opinion- Bioinformatic and Limitation Directives to Help Adopt Genetic Addiction Risk Screening and Identify Preaddictive Reward Dysregulation: Required Analytic Evidence to Induce Dopamine Homeostatsis. | Med Res Arch | 2023 | https://conductscience.org/library/papers/37885438 | PubMed |
| 37599869 | Association between body mass index and treatment completion in extended-release naltrexone-treated patients with opioid dependence. | Front Psychiatry | 2023 | https://conductscience.org/library/papers/37599869 | PubMed |
| 36618806 | Offering a putative neurobiological "dopamine homeostatic" solution to overcome the perils of the reward deficiency syndrome pandemic: emergence of "precision behavioral management". | Ann Transl Med | 2022 | https://conductscience.org/library/papers/36618806 | PubMed |
| 36579510 | Genetic Addiction Risk and Psychological Profiling Analyses for "Preaddiction" Severity Index. | J Pers Med | 2022 | https://conductscience.org/library/papers/36579510 | PubMed |
| 36556236 | Future Newborns with Opioid-Induced Neonatal Abstinence Syndrome (NAS) Could Be Assessed with the Genetic Addiction Risk Severity (GARS) Test and Potentially Treated Using Precision Amino-Acid Enkephalinase Inhibition Therapy (KB220) as a Frontline Modality Instead of Potent Opioids. | J Pers Med | 2022 | https://conductscience.org/library/papers/36556236 | PubMed |
| 36143203 | DNA Directed Pro-Dopamine Regulation Coupling Subluxation Repair, H-Wave® and Other Neurobiologically Based Modalities to Address Complexities of Chronic Pain in a Female Diagnosed with Reward Deficiency Syndrome (RDS): Emergence of Induction of "Dopamine Homeostasis" in the Face of the Opioid Crisis. | J Pers Med | 2022 | https://conductscience.org/library/papers/36143203 | PubMed |
| 35954830 | Prenatal Effects of Nicotine on Obesity Risks: A Narrative Review. | Int J Environ Res Public Health | 2022 | https://conductscience.org/library/papers/35954830 | PubMed |
| 35681980 | Precision Behavioral Management (PBM) and Cognitive Control as a Potential Therapeutic and Prophylactic Modality for Reward Deficiency Syndrome (RDS): Is There Enough Evidence? | Int J Environ Res Public Health | 2022 | https://conductscience.org/library/papers/35681980 | PubMed |
| 35096419 | Hypothesizing High Negative Emotionality as a Function of Genetic Addiction Risk Severity (GARS) Testing in Alcohol Use Disorder (AUD). | J Syst Integr Neurosci | 2020 | https://conductscience.org/library/papers/35096419 | PubMed |
| 35010811 | Hypothesizing in the Face of the Opioid Crisis Coupling Genetic Addiction Risk Severity (GARS) Testing with Electrotherapeutic Nonopioid Modalities Such as H-Wave Could Attenuate Both Pain and Hedonic Addictive Behaviors. | Int J Environ Res Public Health | 2022 | https://conductscience.org/library/papers/35010811 | PubMed |
| 34770047 | Reward Deficiency Syndrome (RDS): A Cytoarchitectural Common Neurobiological Trait of All Addictions. | Int J Environ Res Public Health | 2021 | https://conductscience.org/library/papers/34770047 | PubMed |
Genes10
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| COMT | 1312 | PubTator's text mining | https://conductscience.org/library/genes/1312 | NCBI Gene |
| DRD1 | 1812 | PubTator's text mining | https://conductscience.org/library/genes/1812 | NCBI Gene |
| DRD2 | 1813 | PubTator's text mining | https://conductscience.org/library/genes/1813 | NCBI Gene |
| DRD3 | 1814 | PubTator's text mining | https://conductscience.org/library/genes/1814 | NCBI Gene |
| DRD4 | 1815 | PubTator's text mining | https://conductscience.org/library/genes/1815 | NCBI Gene |
| MAOA | 4128 | PubTator's text mining | https://conductscience.org/library/genes/4128 | NCBI Gene |
| POMC | 5443 | PubTator's text mining | https://conductscience.org/library/genes/5443 | NCBI Gene |
| SLC6A3 | 6531 | PubTator's text mining | https://conductscience.org/library/genes/6531 | NCBI Gene |
| SLC6A4 | 6532 | PubTator's text mining | https://conductscience.org/library/genes/6532 | NCBI Gene |
| ZBTB12 | 221527 | PubTator's text mining | https://conductscience.org/library/genes/221527 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33809702
GET https://conductscience.org/api/papers/v1/33809702/references?page=2